Chitotriosidase as a novel biomarker of early atherosclerosis in hemodialysis patients

Hemodial Int. 2017 Jan;21(1):41-46. doi: 10.1111/hdi.12451. Epub 2016 Jul 4.

Abstract

Introduction: Increasing evidence suggests that inflammation and increased macrophage activity have a central role in pathogenesis of atherosclerosis. It is shown that chitotriosidase (CHIT-1) is a marker of macrophage activity in atherosclerotic plaque, and is found associated with severity of atherosclerotic lesion. There is no data about CHIT-1 activity of hemodialysis patients in the literature. Thus, we hypothesized that in hemodialysis patients, CHIT-1 levels might be a novel biomarker in early atherosclerosis.

Methods: Forty-five hemodialysis patients were included in the study (age: 61.93 ± 13.34). Intima media thickness (IMT) was evaluated with high-resolution B-mode ultrasonography. Biomarker levels were measured in serum of patients.

Findings: We found positive correlation among IMT, age (R: 0.426, P: 0.004) and, CHIT-1 value (R: 0.462, P: 0.001) in spearman correlation analysis. When age, CRP, creatinine, P, Alb, CHIT-1 were chosen as measures that can effect IMT in multiple regression model, IMT level was related with CHIT-1 (Beta: 0,396, P: 0.012) and age (Beta: 0,313 P: 0,048) independently.

Discussion: In conclusion, this is the first report showing that serum CHIT-1 level was related independently with carotid IMT in hemodialysis patients. This biomarker might have an unknown role in the development of atherosclerosis during uremia.

Keywords: Chitotriosidase (CHIT-1); atherosclerosis; hemodialysis; intima media thickness.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Atherosclerosis / blood*
  • Biomarkers / blood*
  • Female
  • Hexosaminidases / metabolism*
  • Humans
  • Male
  • Middle Aged
  • Renal Dialysis / adverse effects*
  • Risk Factors
  • Young Adult

Substances

  • Biomarkers
  • Hexosaminidases
  • chitotriosidase